Mortality in adults with sickle cell disease and pulmonary hypertension.
作者信息
Mehari Alem, Gladwin Mark T, Tian Xin, Machado Roberto F, Kato Gregory J
机构信息
College of Medicine, Howard University, Washington, DC, USA.
出版信息
JAMA. 2012 Mar 28;307(12):1254-6. doi: 10.1001/jama.2012.358.
Abstract
摘要
相似文献
1
Mortality in adults with sickle cell disease and pulmonary hypertension.患有镰状细胞病和肺动脉高压的成年人的死亡率。
JAMA. 2012 Mar 28;307(12):1254-6. doi: 10.1001/jama.2012.358.
2
Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell disease.经肺梯度升高和心脏磁共振成像显示的右心室重塑预示镰状细胞病预后不良。
Haematologica. 2016 Feb;101(2):e40-3. doi: 10.3324/haematol.2015.125229. Epub 2015 Nov 20.
3
N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.镰状细胞病中N末端前脑钠肽水平与死亡风险
JAMA. 2006 Jul 19;296(3):310-8. doi: 10.1001/jama.296.3.310.
4
Pulmonary hypertension in sickle cell disease.镰状细胞病中的肺动脉高压
Am J Cardiol. 1994 Sep 15;74(6):626-8. doi: 10.1016/0002-9149(94)90760-9.
5
Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different.镰状细胞病患者的肺动脉高压：虽不常见但却独特。
Eur Respir J. 2012 Jan;39(1):3-4. doi: 10.1183/09031936.00119811.
6
Hemodynamic predictors of mortality in adults with sickle cell disease.镰状细胞病成人死亡的血流动力学预测因素。
Am J Respir Crit Care Med. 2013 Apr 15;187(8):840-7. doi: 10.1164/rccm.201207-1222OC.
7
Pulmonary hypertension in sickle cell disease: diagnosis and management.镰状细胞病中的肺动脉高压：诊断与管理
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):425-31. doi: 10.1182/asheducation-2014.1.425. Epub 2014 Nov 18.
8
Pulmonary hypertension and NO in sickle cell.镰状细胞病中的肺动脉高压与一氧化氮
Blood. 2010 Aug 5;116(5):852-4. doi: 10.1182/blood-2010-04-282095.
9
Sickle related events following cardiac catheterisation: risk implication for other invasive procedures.心脏导管插入术后与镰状细胞相关的事件：对其他侵入性操作的风险影响
Br J Haematol. 2019 May;185(4):778-780. doi: 10.1111/bjh.15618. Epub 2018 Oct 23.
10
Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease.右心导管术诊断镰状细胞病中的肺动脉高压。
Eur Respir J. 2012 Jan;39(1):112-8. doi: 10.1183/09031936.00134410. Epub 2011 Jul 20.
引用本文的文献
1
Rare but serious: pulmonary vascular disease around the world.罕见但严重：全球范围内的肺血管疾病
JHLT Open. 2025 Jul 18;9:100327. doi: 10.1016/j.jhlto.2025.100327. eCollection 2025 Aug.
2
Clinical Study to Evaluate the Possible Efficacy and Safety of L-Arginine in Children with Sickle Cell Disease and Increased Tricuspid Regurgitant Jet Velocity: a Randomized Controlled Trial.评估L-精氨酸对镰状细胞病合并三尖瓣反流喷射速度增加患儿的可能疗效和安全性的临床研究：一项随机对照试验
Paediatr Drugs. 2025 Jun 17. doi: 10.1007/s40272-025-00701-w.
3
Pulmonary hypertension aetiologies in different parts of the world.世界各地肺动脉高压的病因。
Int J Cardiol Congenit Heart Dis. 2025 Apr 15;20:100586. doi: 10.1016/j.ijcchd.2025.100586. eCollection 2025 Jun.
4
Global prevalence of elevated estimated pulmonary artery systolic pressure in clinically stable children and adults with sickle cell disease: A systematic review and meta-analysis.镰状细胞病临床稳定的儿童和成人中估计肺动脉收缩压升高的全球患病率：一项系统评价和荟萃分析。
PLoS One. 2025 Feb 13;20(2):e0318751. doi: 10.1371/journal.pone.0318751. eCollection 2025.
5
Pulmonary Hypertension in the Field of Hematological and Oncological Diseases.血液学和肿瘤学疾病领域的肺动脉高压
Respiration. 2025;104(7):466-475. doi: 10.1159/000544126. Epub 2025 Feb 12.
6
Circulating free heme induces cytokine storm and pulmonary hypertension through the MKK3/p38 axis.循环游离血红素通过 MKK3/p38 轴诱导细胞因子风暴和肺动脉高压。
Am J Physiol Lung Cell Mol Physiol. 2024 Oct 1;327(4):L574-L586. doi: 10.1152/ajplung.00422.2022. Epub 2024 Aug 28.
7
End Organ Affection in Sickle Cell Disease.镰状细胞病的靶器官损害。
Cells. 2024 May 29;13(11):934. doi: 10.3390/cells13110934.
8
Diagnosis and management of chronic thromboembolic pulmonary hypertension (CTEPH) in sickle cell disease: A review.镰状细胞病中慢性血栓栓塞性肺动脉高压（CTEPH）的诊断与管理：综述
Pulm Circ. 2024 May 27;14(2):e12362. doi: 10.1002/pul2.12362. eCollection 2024 Apr.
9
Cardiovascular Consequences of Sickle Cell Disease.镰状细胞病的心血管后果
J Blood Med. 2024 May 6;15:207-216. doi: 10.2147/JBM.S455564. eCollection 2024.
10
Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology.镰状细胞病中的肺动脉高压：与病理生理学相关的基因多态性的新发现。
Int J Mol Sci. 2024 Apr 27;25(9):4792. doi: 10.3390/ijms25094792.
本文引用的文献
1
Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease.右心导管术诊断镰状细胞病中的肺动脉高压。
Eur Respir J. 2012 Jan;39(1):112-8. doi: 10.1183/09031936.00134410. Epub 2011 Jul 20.
2
A hemodynamic study of pulmonary hypertension in sickle cell disease.镰状细胞病中肺动脉高压的血液动力学研究。
N Engl J Med. 2011 Jul 7;365(1):44-53. doi: 10.1056/NEJMoa1005565.
3
Pulmonary hypertension and nitric oxide depletion in sickle cell disease.镰状细胞病中的肺动脉高压和一氧化氮耗竭。
Blood. 2010 Aug 5;116(5):687-92. doi: 10.1182/blood-2010-02-268193. Epub 2010 Apr 15.
4
Pulmonary hypertension in patients with sickle cell disease: a longitudinal study.镰状细胞病患者的肺动脉高压：一项纵向研究。
Br J Haematol. 2006 Jul;134(1):109-15. doi: 10.1111/j.1365-2141.2006.06110.x.
5
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.肺动脉高压作为镰状细胞病患者死亡的一个危险因素。
N Engl J Med. 2004 Feb 26;350(9):886-95. doi: 10.1056/NEJMoa035477.
Zotero 插件